Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)

Market Cap	7.53B
Revenue (ttm)	3.97B
Net Income (ttm)	235.20M
Shares Out	1.02B
EPS (ttm)	0.23
PE Ratio	32.21
Forward PE	25.18
Dividend	0.12 (1.62%)
Ex-Dividend Date	n/a

Volume	11,816,735
Average Volume	21,267,056
Open	7.35
Previous Close	7.41
Day's Range	7.35 - 7.47
52-Week Range	5.74 - 9.39
Beta	1.74
RSI	45.26
Earnings Date	Apr 25, 2025

About SHA:600223

Lushang Freda Pharmaceutical Co.,Ltd. engages in the production and sales of pharmaceuticals, raw materials, and additives in China. The company is involved in cosmetics and medicine businesses. It produces cleansers, lotions, creams, essences, masks, and other products. In addition, the company offers dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, and accelerates project research and investigation areas. It serves hospitals, primary medical institutions, and chain drug stores, etc. The company was formerly known as Lushan...

• Industry: Real Estate - Development
• Sector: Real Estate
• Founded: 1993
• Employees: 3,630
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600223

Financial Performance

In 2024, SHA:600223's revenue was 3.98 billion, a decrease of -13.02% compared to the previous year's 4.58 billion. Earnings were 243.53 million, a decrease of -19.73%.